Brief: Curasight A/S Says It Submits Clinical Trial Application For Phase 1 Trial With Utreat In Brain Cancer Patients
18/06/2025 16:36
June 18 (Reuters) - Curasight A/S CURAS.TE: CURASIGHT A/S SUBMITS CLINICAL TRIAL APPLICATION FOR PHASE 1 TRIAL WITH UTREAT[®] IN BRAIN CANCER PATIENTS Source text: ID:nWkr85Gd5H Further company coverage: CURAS.TE ((Reuters.Briefs@thomsonreuters.com;))